Human ENG (CD105) knockout HeLa cell pellet (ab279012)
Properties
-
Storage instructions
Store at -80°C. Please refer to protocols. -
Components 1 kit Human ENG knockout HeLa cell pellet 1 vial Human wild-type HeLa cell pellet 1 vial -
Research areas
-
Cell type
epithelial -
Disease
Adenocarcinoma -
Gender
Female -
STR Analysis
Amelogenin X D5S818: 11, 12 D13S317: 12, 13.3 D7S820: 8, 12 D16S539: 9, 10 vWA: 16, 18 TH01: 7 TPOX: 8,12 CSF1PO: 9, 10
Images
-
Western blot - Human ENG (CD105) knockout HeLa cell pellet (ab279012)
Lane 1: Wild-type HeLa cell lysate (20 µg)
Lane 2: ENG knockout HeLa cell lysate (20 µg)
Lane 3: HUVEC cell lysate (20 µg)
Lane 4: MCF7 cell lysate (20 µg)
Lanes 1-4: Merged signal (red and green). Green - ab170943 observed at 70-120 kDa. Red - loading control ab8245 observed at 37 kDa.
ab170943 Anti-CD105 antibody [EPR10145-10] was shown to specifically react with CD105 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265178 (knockout cell lysate ab256906) was used. Wild-type and CD105 knockout samples were subjected to SDS-PAGE. ab170943 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
-
Western blot - Human ENG (CD105) knockout HeLa cell pellet (ab279012)Lane 1: Wild-type HeLa cell lysate (20 µg)
Lane 2: ENG knockout HeLa cell lysate (20 µg)
Lane 3: HUVEC cell lysate (20 µg)
Lane 4: MCF7 cell lysate (20 µg)
Lanes 1-4: Merged signal (red and green). Green - ab169545 observed at 70-120 kDa. Red - loading control ab8245 observed at 37 kDa.
ab169545 Anti-CD105 antibody [EPR10145-12] was shown to specifically react with CD105 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265178 (knockout cell lysate ab256906) was used. Wild-type and CD105 knockout samples were subjected to SDS-PAGE. ab169545 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
-
Sanger Sequencing - Human ENG (CD105) knockout HeLa cell pellet (ab279012)Allele-1: 19 bp deletion in exon2
-
Sanger Sequencing - Human ENG (CD105) knockout HeLa cell pellet (ab279012)Allele-2: 11 bp deletion in exon2
-
Sanger Sequencing - Human ENG (CD105) knockout HeLa cell pellet (ab279012)Allele-3: 1 bp insertion in exon2
